ArticleOncology letters2016

UGT1A1*6, UGT1A7*3 and UGT1A9*1b polymorphisms are predictive markers for severe toxicity in patients with metastatic gastrointestinal cancer treated with irinotecan-based regimens.

Chengxu Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.